The role of microRNAs in colorectal cancer

Journal of Genetics and Genomics

Volumn 37, Issue 6, 2010, Pages 347-358

  Liu, Mao ^a   Chen, Huiping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Biomarker; Cancer therapy; Colorectal cancer; MicroRNAs; Signal pathway

Indexed keywords

APC PROTEIN; CELL MARKER; MICRORNA; TUMOR MARKER;

APOPTOSIS; BIOGENESIS; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; INFLAMMATION; ONCOGENE; PROGNOSIS; REVIEW; STEM CELL; TUMOR SUPPRESSOR GENE; ANIMAL; COLORECTAL TUMOR; GENETIC EPISTASIS; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; COLORECTAL NEOPLASMS; EPISTASIS, GENETIC; HUMANS; MICRORNAS; ONCOGENES; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77954162817     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(09)60053-9     Document Type: Review

References (81)

1. Akao Y., Nakagawa Y., Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull. 2006, 29:903-906.
2. Ambros V. The evolution of our thinking about microRNAs. Nat. Med. 2008, 14:1036-1040.
3. Arndt G.M., Dossey L., Cullen L.M., Lai A., Druker R., Eisbacher M., Zhang C.Y., Tran N., Fan H.T., Retzlaff K., Bittner A., Raponi M. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009, 9:17.
4. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
5. Bandres E., Agirre X., Bitarte N., Ramirez N., Zarate R., Roman-Gomez J., Prosper F., Garcia-Foncillas J. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 2009, 125:2737-2743.
6. Bandres E., Bitarte N., Arias F., Agorreta J., Fortes P., Agirre X., Zarate R., Diaz-Gonzalez J.A., Ramirez N., Sola J.J., Jimenez P., Rodriguez J., Garcia-Foncillas J. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res. 2009, 15:2281-2290.
7. Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzo M., Garcia-Foncillas J. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 2006, 5:10.
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
9. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., Fearon E.R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17:1298-1307.
10. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., D'Urso L., Pagliuca A., Biffoni M., Labbaye C., Bartucci M., Muto G., Peschle C., De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 2008, 14:1271-1277.
11. Boyle P., Levin B. Colorectal Cancer. World Cancer Report 2008 2008, 374-378. International Agency for Research on Cancer, Lyon, France.
12. Brown B.D., Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 2009, 10:578-585.
13. Brown B.D., Venneri M.A., Zingale A., Sergi L.S., Naldini L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 2006, 12:585-591.
14. Brown B.D., Gentner B., Cantore A., Colleoni S., Amendola M., Zingale A., Baccarini A., Lazzari G., Galli C., Naldini L. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 2007, 25:1457-1467.
15. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
16. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y.S., Dalton N.D., Elia L., Latronico M.V.G., Hoydal M., Autore C., Russo M.A., Dorn G.W., Ellingsen O., Ruiz-Lozano P., Peterson K.L., Croce C.M., Peschle C., Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
17. Chen X., Guo X., Zhang H., Xiang Y., Chen J., Yin Y., Cai X., Wang K., Wang G., Ba Y., Zhu L., Wang J., Yang R., Zhang Y., Ren Z., Zen K., Zhang J., Zhang C.Y. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392.
18. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H.T., Mendell J., Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006, 38:1060-1065.
19. Diosdado B., van de Wiel M., Droste J., Mongera S., Postma C., Meijerink W., Carvalho B., Meijer G.A. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer 2009, 101:707-714.
20. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Meth. 2007, 4:721-726.
21. Edge R.E., Falls T.J., Brown C.W., Lichty B.D., Atkins H., Bell J.C. A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 2008, 16:1437-1443.
22. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C.D., Chan K.K., Marcucci G., Calin G.A., Huebner K., Croce C.M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104:15805-15810.
23. Faber C., Kirchner T., Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch. 2009, 454:359-367.
24. Fang W., Lin C., Zhang H., Qian J., Zhong L., Xu N. Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. J. Int. Med. Res. 2007, 35:716-723.
25. Fodde R., Smits R., Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 2001, 1:55-67.
26. Gentner B., Schira G., Giustacchini A., Amendola M., Brown B.D., Ponzoni M., Naldini L. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Meth. 2009, 6:63-66.
27. Gregory R.I., Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005, 65:3509-3512.
28. Guo C.G., Sah J.F., Beard L., Willson J.K.V., Markowitz S.D., Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008, 47:939-946.
29. He X.-X., Chen K., Yang J., Li X.-Y., Gan H.-Y., Liu C.-Y., Coleman T.R., Al-Abed Y. Macrophage migration inhibitory factor promotes colorectal cancer. Mol. Med. 2009, 15:1-10.
30. Huang Z.M., Yang J., Shen X.Y., Zhang X.Y., Meng F.S., Xu J.T., Zhang B.F., Gao H.J. MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer. J. Dig. Dis. 2009, 10:188-194.
31. Hudson J.D., Shoaibi M.A., Maestro R., Carnero A., Hannon G.J., Beach D.H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 1999, 190:1375-1382.
32. Jiang S.-X., Wang X.-S., Geng C.-H., Wang G.-Y. Altering trend of clinical characteristics of colorectal cancer: a report of 3,607 cases. Chin. J. Cancer 2009, 28:54-56.
33. Korpal M., Lee E.S., Hu G.H., Kang Y.B. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
34. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
35. Lanza G., Ferracin M., Gafa R., Veronese A., Spizzo R., Pichiorri F., Liu C.G., Calin G.A., Croce C.M., Negrini M. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer 2007, 6:11.
36. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
37. Lee H., Rhee H., Kang H.J., Kim H.S., Min B.S., Kim N.K., Kim H. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am. J. Clin. Pathol. 2008, 129:772-779.
38. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
39. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to Lin-14. Cell 1993, 75:843-854.
40. Legendre H., Decaestecker C., Nagy N., Hendlisz A., Schuring M.P., Salmon I., Gabius H.J., Pector J.C., Kiss R. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod. Pathol. 2003, 16:491-504.
41. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebet B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
42. Michael M.Z., O'Connor S.M., Pellekaan N.G.V., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
43. Miyaki M., Iijima T., Kimura J., Yasuno M., Mori T., Hayashi Y., Koike M., Shitara N., Iwama T., Kuroki T. Frequent mutation of ss-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 1999, 59:4506-4509.
44. Motoyama K., Inoue H., Takatsuno Y., Tanaka F., Mimori K., Uetake H., Sugihara K., Mori M. Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol. 2009, 34:1069-1075.
45. Nagel R., le Sage C., Diosdado B., van der Waal M., Vrielink J., Bolijn A., Meijer G.A., Agami R. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res. 2008, 68:5795-5802.
46. Nakajima G., Hayashi K., Xi Y., Kudo K., Uchida K., Takasaki K., Yamamoto M., Ju J. Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 2006, 3:317-324.
47. Ng E.K.O., Tsang W.P., Ng S.S.M., Jin H.C., Yu J., Li J.J., Rocken C., Ebert M.P.A., Kwok T.T., Sung J.J.Y. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 2009, 101:699-706.
48. Ohkawara T., Nishihira J., Takeda H., Asaka M., Sugiyama T. Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders. J. Gastroenterol. 2005, 40:117-122.
49. Schepeler T., Reinert J.T., Ostenfeld M.S., Christensen L.L., Silahtaroglu A.N., Dyrskjot L., Wiuf C., Sorensen F.J., Kruhoffer M., Laurberg S., Kauppinen S., Orntoft T.F., Andersen C.L. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008, 68:6416-6424.
50. Scherr M., Venturini L., Battmer K., Schaller-Schoenitz M., Schaefer D., Dallmann I., Ganser A., Eder M. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 2007, 35:22.
51. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L.W., Au G.K.H., Liu C.G., Calin G.A., Croce C.M., Harris C.C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. J. Am. Med. Assoc. 2008, 299:425-436.
52. Schimanski C.C., Frerichs K., Rahman F., Berger M., Lang H., Galle P.R., Moehler M., Gockel I. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J. Gastroenterol. 2009, 15:2089-2096.
53. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
54. Shell S., Park S.M., Radiabi A.R., Schickel R., Kistner E.O., Jewell D.A., Feig C., Lengyel E., Peter M.E. Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. USA 2007, 104:11400-11405.
55. Singh S.K., Bhadra M.P., Girschick H.J., Bhadra U. MicroRNAs-micro in size but macro in function. FEBS J. 2008, 275:4929-4944.
56. Slaby O., Svoboda M., Fabian P., Smerdova T., Knoflickova D., Bednarikova M., Nenutil R., Vyzula R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72:397-402.
57. Spaderna S., Schmalhofer O., Hlubek F., Berx G., Eger A., Merkel S., Jung A., Kirchner T., Brabletz T. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006, 131:830-840.
58. Spaderna S., Schmalhofer O., Wahlbuhl M., Dimmler A., Bauer K., Sultan A., Hlubek F., Jung A., Strand D., Eger A., Kirchner T., Behrens J., Brabletz T. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008, 68:537-544.
59. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998, 58:1130-1134.
60. Steinbach G., Lynch P.M., Phillips R.K.S., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.K., Levin B., Godio L., Patterson S., Rodriguez-Bigas M.A., Jester S.L., King K.L., Schumacher M., Abbruzzese J., DuBois R.N., Hittelman W.N., Zimmerman S., Sherman J.W., Kelloff G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 2000, 342:1946-1952.
61. Strillacci A., Griffoni C., Sansone P., Paterini P., Piazzi G., Lazzarini G., Spisni E., Pantaleo M.A., Biasco G., Tomasi V. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res. 2009, 315:1439-1447.
62. Sureban S.M., May R., Ramalingam S., Subramaniam D., Natarajan G., Anant S., Houchen C.W. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a microRNA-dependent mechanism. Gastroenterology 2009, 137:649-659.
63. Suzuki T., Sakurai F., Nakamura S.I., Kouyama E., Kawabata K., Kondoh M., Yagi K., Mizuguchi H. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol. Ther. 2008, 16:1719-1726.
64. Tay Y., Zhang J.Q., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
65. Tazawa H., Tsuchiya N., Izumiya M., Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA 2007, 104:15472-15477.
66. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
67. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., Tokino T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008, 68:4123-4132.
68. Tsang W.P., Kwok T.T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008, 13:1215-1222.
69. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA 1997, 94:3336-3340.
70. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X.S., Ateeq B., Laxman B., Cao X.H., Jing X.J., Ramnarayanan K., Brenner J.C., Yu J.D., Kim J.H., Han B., Tan P., Kumar-Sinha C., Lonigro R.J., Palanisamy N., Maher C.A., Chinnaiyan A.M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
71. Wang C.J., Zhou Z.G., Wang L., Yang L., Zhou B., Gu J., Chen H.Y., Sun X.F. Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Dis. Markers 2009, 26:27-34.
72. Wang P., Zou F.D., Zhang X.D., Li H., Dulak A., Tomko R.J., Lazo J.S., Wang Z., Zhang L., Yu J. MicroRNA-21 megatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009, 69:8157-8165.
73. Wang X., Lam E.K.Y., Zhang J.B., Jin H.C., Sung J.J.Y. MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. Biochem. Biophys. Res. Commun. 2009, 387:376-380.
74. Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V.G., Morton J., Sansom O., Schuler J., Stemmler M.P., Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11:1487-1495.
75. Wilson J.M., Coletta P.L., Cuthbert R.J., Scott N., MacLennan K., Hawcroft G., Leng L., Lubetsky J.B., Jin K.K., Lolis E., Medina F., Brieva J.A., Poulsom R., Markham A.F., Bucala R., Hull M.A. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 2005, 129:1485-1503.
76. Xi Y., Formentini A., Chien M., Weir D.B., Russo J.J., Ju J., Kornmann M., Ju J. Prognostic values of microRNAs in colorectal cancer. Biomark Insights 2006, 2:113-121.
77. Xu T., Zhu Y., Xiong Y.J., Ge Y.Y., Yun J.P., Zhuang S.M. MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. Hepatology 2009, 50:113-121.
78. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 2008, 105:13421-13426.
79. Yasasever V., Camlica H., Duranyildiz D., Oguz H., Tas F., Dalay N. Macrophage migration inhibitory factor in cancer. Cancer Investig. 2007, 25:715-719.
80. Ylosmaki E., Hakkarainen T., Hemminki A., Visakorpi T., Andino R., Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J. Virol. 2008, 82:11009-11015.
81. Zhao H.Y., Ooyama A., Yamamoto M., Ikeda R., Haraguchi M., Tabata S., Furukawa T., Che X.F., Iwashita K.I., Oka T., Fukushima M., Nakagawa M., Ono M., Kuwano M., Akiyama S.I. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells. Cancer Lett. 2008, 270:156-163.